4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-006323
Director sold 5,000 shares at an average $58.69 ($293,458)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Henderson Jeffrey William Director | 2025-03-03 | Sale 10b5-1 | −1,795 | $57.93 | $103,992 | 36,816 | D |
| Henderson Jeffrey William Director | 2025-03-03 | Sale 10b5-1 | −3,205 | $59.12 | $189,467 | 33,611 | D |
| Open-market sales · 5,000 sh · avg $58.69 · $293,458 | |||||||
Loading xslF345X05/form4-03042025_010322.xml…